47045-BDI-T-PNILT-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>PROGRAMME NATIONAL INTEGRE LEPRE ET TUBERCULOSE - Burundi (01-Mar-2016-31-Dec-2017)</narrative> Burundi is a country of an estimated 10.1 million inhabitants in a 27,830 square-kilometre territory. Tuberculosis (TB) incidence (all forms) has more than halved between 2000 (288 per 100,000) and 2014 (126 per 100,000).(WHO). However, case detection is low (53%, all forms), and the estimated prevalence of tuberculosis (including HIV-positive TB patients) is 195 per 100,000 (WHO, 2014). The estimated burden of multidrug-resistent (MDR)-TB is 2.2% among new TB cases, and 11% among retreatment cases, and HIV prevalence among TB patients is 15%. This grant focuses on increasing case detection and treatment of TB and multidrug-resistant (MDR)-TB during the period of 2015-2017. Strategies include the increased access and use of new TB diagnostic techniques such as GeneExperts, the cooperation between the PNLT and theNational AIDS Control Program (PNLS) for improved care among co-infected patients, improved case management in the community and the continuation of the MDR-TB program. The interventions are aligned with the country’s National Strategic Plan for TB (2014-2020), as well the joint TB-HIV action plan for the period 2015-2017. The National Integrated Leprosy and Tuberculosis Control Programme (PNILT) has been the Principal Recipient for TB grants under Round 4, Round 7 and the Transitional Funding Mechanism (TFM), with satisfactory programmatic performance ratings. Goal: To contribute to improving the health of the Burundian population by reducing the burden of tuberculosis. Objectives: To improve TB prevention (control of the infection in health care facilities, behavior change in the general population and prevention with drugs), to increase the percentage of the population with adequate knowledge of TB from 76 percent to 90 percent in 2018; To improve the TB control program's management capacities, surveillance, and the system for monitoring and evaluation and operational research; To increase early detection from 7,547 to 9,643 TBAF cases in the general population, including the high-risk groups (PLHIV, refugees, prisoners, children), i.e. a 22 percent increase from 2013 to 2017; To increase testing of MDR-TB cases from 49 to 140 expected cases according to the WHO estimate, i.e. an increase of 91 cases from 2014 to 2017; To maintain the treatment success rate for new bacteriologically confirmed patients and MDR-TB cases at over 90 percent. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi Ministry of Public Health and Fight against AIDS of the Republic of Burundi The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Gilles Cesari Fund Portfolio Manager +41 58 791 1700 gilles.cesari@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burundi Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 6983959.00 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 770564.87 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 23682.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 216608.68 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 124224.03 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 479622.62 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 752071.54 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 50000.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 98920.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 897271.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 174077.69 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 386608.22 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 574001.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi -2436307.35 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 407426.25 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 250477.13 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 119355.12 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 37594.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 25000.00 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 25000.00 Global Fund disbursement to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 1257.07 Funds returned to the Global Fund from BDI-T-PNILTP01. Ministry of Public Health and Fight against AIDS of the Republic of Burundi The Global Fund to Fight AIDS, Tuberculosis and Malaria -1257.07 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi 140980.15 Funds returned to the Global Fund from BDI-T-PNILTP01. Ministry of Public Health and Fight against AIDS of the Republic of Burundi The Global Fund to Fight AIDS, Tuberculosis and Malaria -140980.15 Global Fund commitment to BDI-T-PNILTP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Ministry of Public Health and Fight against AIDS of the Republic of Burundi <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 49. Numerator: 51. Numerator: 41. Numerator: 51. Numerator: 39; Denominator: 39; Percentage: 100%. Numerator: 70. Numerator: 17; Denominator: 17; Percentage: 100%. Numerator: 70. Numerator: 33; Denominator: 33; Percentage: 100%. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 289; Denominator: 289. Numerator: 177; Denominator: 177. Numerator: 101; Denominator: 152. Numerator: 177; Denominator: 177. Numerator: 154; Denominator: 182. Numerator: 191; Denominator: 191. Numerator: 127; Denominator: 164. Numerator: 191; Denominator: 191. Numerator: 101; Denominator: 150. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Module: RSSH: Health management information systems and M&E. <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 171; Denominator: 171. Numerator: 169; Denominator: 169. Numerator: 170; Denominator: 170. Numerator: 169; Denominator: 169. Numerator: 170; Denominator: 170. <narrative>DOTS-other 1: Percentage of TB testing and treatment centers (TTC) without stock-outs (one week or more) of firstline TB drugs during the reporting period</narrative> Module: TB care and prevention. <narrative>DOTS-other 1: Percentage of TB testing and treatment centers (TTC) without stock-outs (one week or more) of firstline TB drugs during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 170; Denominator: 170. Numerator: 169; Denominator: 169. Numerator: 171; Denominator: 171. Numerator: 169; Denominator: 169. Numerator: 170; Denominator: 170. Numerator: 169; Denominator: 169. Numerator: 170; Denominator: 170. <narrative>DOTS-other 2: Number and percentage of TB (all forms) among children (notified and projected), among all notified cases (all forms, adults and children)</narrative> Module: TB care and prevention. <narrative>DOTS-other 2: Number and percentage of TB (all forms) among children (notified and projected), among all notified cases (all forms, adults and children)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 528; Denominator: 7309. Numerator: 449; Denominator: 4487. Numerator: 200; Denominator: 3847. Numerator: 449; Denominator: 4487. Numerator: 192; Denominator: 3815. Numerator: 627; Denominator: 4822. Numerator: 240; Denominator: 4052. Numerator: 627; Denominator: 4822. Numerator: 186; Denominator: 3810. <narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Module: TB care and prevention. <narrative>Number of children <5 in contact with TB patients who began isonizide preventive therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Module: TB care and prevention. <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Module: TB care and prevention. <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4236; Denominator: 4509. Numerator: 2520; Denominator: 2681. Numerator: 1859; Denominator: 1977. Numerator: 2520; Denominator: 2681. Numerator: 1958; Denominator: 2091. Numerator: 2708; Denominator: 2881. Numerator: 1985; Denominator: 2130. Numerator: 2708; Denominator: 2881. Numerator: 2068; Denominator: 2213. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 0; Denominator: 169. Numerator: 169; Denominator: 169. Numerator: 169; Denominator: 171. Numerator: 169; Denominator: 169. Numerator: 167; Denominator: 168. Numerator: 169; Denominator: 169. Numerator: 154; Denominator: 160. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 611; Denominator: 901. Numerator: 531; Denominator: 633. Numerator: 402; Denominator: 456. Numerator: 531; Denominator: 633. Numerator: 393; Denominator: 421. Numerator: 653; Denominator: 695. Numerator: 426; Denominator: 451. Numerator: 653; Denominator: 695. Numerator: 431; Denominator: 436. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Module: TB/HIV. <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 6654; Denominator: 7309. Numerator: 4217; Denominator: 4487. Numerator: 3706; Denominator: 3847. Numerator: 4217; Denominator: 4487. Numerator: 3639; Denominator: 3815. Numerator: 4629; Denominator: 4822. Numerator: 3917; Denominator: 4052. Numerator: 4629; Denominator: 4822. Numerator: 3776; Denominator: 3810.